257 related articles for article (PubMed ID: 18487521)
1. Attitudes toward attention-deficit hyperactivity disorder (ADHD) treatment: parents' and children's perspectives.
Berger I; Dor T; Nevo Y; Goldzweig G
J Child Neurol; 2008 Sep; 23(9):1036-42. PubMed ID: 18487521
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
Yang P; Hsu HY; Chiou SS; Chao MC
Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
[TBL] [Abstract][Full Text] [Related]
3. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
[TBL] [Abstract][Full Text] [Related]
4. Social acceptability of methylphenidate and behavior modification for treating attention deficit hyperactivity disorder.
Liu C; Robin AL; Brenner S; Eastman J
Pediatrics; 1991 Sep; 88(3):560-5. PubMed ID: 1881737
[TBL] [Abstract][Full Text] [Related]
5. Treatment choices and experiences in attention deficit and hyperactivity disorder: relations to parents' beliefs and attributions.
Johnston C; Seipp C; Hommersen P; Hoza B; Fine S
Child Care Health Dev; 2005 Nov; 31(6):669-77. PubMed ID: 16207224
[TBL] [Abstract][Full Text] [Related]
6. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
Pae CU
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
[No Abstract] [Full Text] [Related]
7. Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.
Findling RL; Wigal SB; Bukstein OG; Boellner SW; Abikoff HB; Turnbow JM; Civil R
Clin Ther; 2009 Aug; 31(8):1844-55. PubMed ID: 19808143
[TBL] [Abstract][Full Text] [Related]
8. Parental angst making and revisiting decisions about treatment of attention-deficit/hyperactivity disorder.
Brinkman WB; Sherman SN; Zmitrovich AR; Visscher MO; Crosby LE; Phelan KJ; Donovan EF
Pediatrics; 2009 Aug; 124(2):580-9. PubMed ID: 19651580
[TBL] [Abstract][Full Text] [Related]
9. [Sociodemographic and clinical factors associated with compliance to methylphenidate treatment in children with attention deficit hyperactivity disorder].
Kiliç BG; Bilgiç A; Gürkan K; Aysev A
Turk Psikiyatri Derg; 2007; 18(3):207-13. PubMed ID: 17853975
[TBL] [Abstract][Full Text] [Related]
10. Children's and parents' perspectives on open-label use of placebos in the treatment of ADHD.
Sandler A; Glesne C; Geller G
Child Care Health Dev; 2008 Jan; 34(1):111-20. PubMed ID: 18171452
[TBL] [Abstract][Full Text] [Related]
11. No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy.
Walitza S; Kämpf K; Artamonov N; Romanos M; Gnana Oli R; Wirth S; Warnke A; Gerlach M; Stopper H
Toxicol Lett; 2009 Jan; 184(1):38-43. PubMed ID: 19015014
[TBL] [Abstract][Full Text] [Related]
12. Attention-deficit-hyperactivity disorder: an update.
Dopheide JA; Pliszka SR
Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
[TBL] [Abstract][Full Text] [Related]
13. Children's self-reports on perceived effects on taking stimulant medication for ADHD.
Thorell LB; Dahlström K
J Atten Disord; 2009 Mar; 12(5):460-8. PubMed ID: 18685139
[TBL] [Abstract][Full Text] [Related]
14. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].
Stasik D; Tucha O; Tucha L; Walitza S; Lange KW
Psychiatr Pol; 2009; 43(2):183-92. PubMed ID: 19697788
[TBL] [Abstract][Full Text] [Related]
15. Update on investigation of Ritalin conspiracy.
J Psychosoc Nurs Ment Health Serv; 2001 Jan; 39(1):10. PubMed ID: 11197990
[No Abstract] [Full Text] [Related]
16. Cytogenetic effects in children treated with methylphenidate.
El-Zein RA; Abdel-Rahman SZ; Hay MJ; Lopez MS; Bondy ML; Morris DL; Legator MS
Cancer Lett; 2005 Dec; 230(2):284-91. PubMed ID: 16297714
[TBL] [Abstract][Full Text] [Related]
17. Educating and counseling of parents of children with attention-deficit hyperactivity disorder.
Ghanizadeh A
Patient Educ Couns; 2007 Sep; 68(1):23-8. PubMed ID: 17467224
[TBL] [Abstract][Full Text] [Related]
18. Absence of cytogenetic effects in children and adults with attention-deficit/hyperactivity disorder treated with methylphenidate.
Ponsa I; Ramos-Quiroga JA; Ribasés M; Bosch R; Bielsa A; Ordeig MT; Morell M; Miró R; de Cid R; Estivill X; Casas M; Bayés M; Cormand B; Hervás A
Mutat Res; 2009 Jun; 666(1-2):44-9. PubMed ID: 19457516
[TBL] [Abstract][Full Text] [Related]
19. Treatment effectiveness of combined medication/behavioural treatment with chinese ADHD children in routine practice.
So CY; Leung PW; Hung SF
Behav Res Ther; 2008 Sep; 46(9):983-92. PubMed ID: 18692170
[TBL] [Abstract][Full Text] [Related]
20. Rates of adherence to pharmacological treatment among children and adolescents with attention deficit hyperactivity disorder.
Ibrahim el SR
Hum Psychopharmacol; 2002 Jul; 17(5):225-31. PubMed ID: 12404679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
